May 16, 2011Date Released: 16 May 2011
CASE CCC IN THE NEWS
Smarter Treatment for Killer Infections
CWRU Researchers Call for Changing How Research is Done
First-of-its-Kind Phase 2 Study Shows Oral Therapy is Viable Treatment Option
MARK YOUR CALENDARSCancer Center Seminar Series: The Ohio Brain Tumor Study: How to do BIG science in a RARE cancer
Friday, May 20
Please join us Friday, May 20 at the next Cancer Center Seminar Series featuring Jill Barnholtz-Sloan, PhD. Dr. Barnholtz-Sloan, Assistant Professor of General Medical Sciences- Oncology, will present The Ohio Brain Tumor Study: How to do BIG science in a RARE cancer.
Dr. Jill Barnholtz-Sloan has been at the Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine since February 2007, with joint appointments in the Department of Epidemiology and Biostatistics and the Center for Proteomics and Bioinformatics. Dr. Barnholtz-Sloan is multi-disciplinary trained in biostatistics, population genetics and human genetics, and the main thrust of her research is in cancer genetic epidemiology and statistical estimation of genetic ancestry for studying racial/ethnic differences in cancer development and clinical outcomes. While the major focus of her independent research program is in brain tumors, she is also involved in funded studies of ovarian, breast, prostate and colon cancers.
Dr. Barnholtz-Sloan has successfully established a multi-center network within Ohio, the Ohio Brain Tumor Study (OBTS), to accrue newly diagnosed brain tumor patients and obtain biospecimens, correlative clinical information and active follow-up. Because of the success of this state-wide network, she was recently awarded a multi-site The Cancer Genome Atlas (TCGA) contract as PI, for OBTS to be one of the TCGA Networks of Tissue Source Sites. In addition, her team has recently been awarded local pilot funds to study methylation and proteomics in brain tumors. She is PI of subcontracts to CWRU for three different multi-center NCI funded studies of gliomas and ovarian cancer. Additionally, in 2009 she was elected Co-Vice President (US) of the Brain Tumor Epidemiology Consortium (BTEC) and will become the co-President (US) in 2012, and is the current President-Elect for the CWRU School of Medicine Faculty Council.Case CCC Annual Scientific Retreat
The Case CCC Annual Scientific Retreat will be July 8-9 at Corporate College East. Details will be posted soon.
FUNDING OPPORTUNITIESPilot Project Grants: American Cancer Society IRG Awards
The Case CCC is currently accepting applications for American Cancer Society Institutional Research Grant (IRG) awards. Pilot funding is available for projects in basic, clinical, prevention and control, behavioral, health services, and epidemiology cancer research with awards up to $30,000 for one-year cancer research projects that provide the basis for future independent grants.
Instructions, frequently asked questions, and application forms are available at http://cancer.case.edu. Contact Terri Daso, Cancer Center Administration (844-7252,firstname.lastname@example.org) for more information.
LOI Deadline: June 13
The Society of Surgical Oncology (SSO) has released a call for applications for the Clinical Investigator Award in Breast Cancer Research funded by Susan G. Komen for the Cure®. The purpose of this award is to promote patient-oriented breast cancer research conducted by surgical oncologists in clinical and translational science. Applicants must be surgical oncologists within 10 years of completion of training and be full SSO members.
Deadline: July 8International Myeloma Foundation Brian D. Novis Research Grant Program
The International Myeloma Foundation (IMF) is accepting applications from both junior and senior investigators for theBrian D. Novis Research Grant program. This program supports investigators conducting cutting-edge studies to provide better treatment, management, prevention, and ultimately, a cure for myeloma.
Deadline: August 1Mesothelioma Research Grants
The Mesothelioma Applied Research Foundation announces the availability of its 2011 round of mesothelioma research grant funding. Continuing its efforts to stimulate translational research for the treatment of malignant mesothelioma, the Meso Foundation is again soliciting applications for funding of innovative projects that address issues for the treatment of the disease. Eligible projects may relate to benchwork, translational or clinical research and may be conducted through any not-for-profit academic, medical or research institution, in the U.S. or abroad.
Deadline: August 5Case CCC Clinical Trials Funding Opportunity
The Case Comprehensive Cancer Center is announcing the availability of Protocol Specific Research Support (PSRS) funding for Year 2011. The budgeted funds are for the conduct of early phase clinical trial and restricted to support research nurses and data managers directly involved in the conduct of these clinical trials. Studies developed jointly between UH and CCF with planned accrual at both institutions will be prioritized. Please direct questions and requests for information about the funding process to Katarzyna Karelus, Administrative Director, Case Comprehensive Cancer Center Clinical Research Office, at (216) 368-6287 email@example.com.
ANNOUNCEMENTSAACR: 2011 Joint Hill Day Summary and Highlights
Message from AACR
Last Wednesday we hosted, along with the Association of American Cancer Institutes, the American Society of Clinical Oncology and the Friends of Cancer Research, a Hill Day in which 80 scientists and cancer center leaders from across the country participated.
In total, nearly 150 meetings with representatives and senators from 32 states were held and the primary message was to support sustained, and ideally increased, funding for the National Institutes of Health (NIH). Leaders from all 4 organizations also had the opportunity to meet with key House and Senate leadership offices, and FDA appropriations were discussed with some offices. Other issues that came up in some meetings were cancer drug shortages and concerns about the scientific workforce.
We are still collecting meeting feedback forms, but in general, attendees reported that members of Congress and their staff were receptive to the message about the importance of NIH funding and cancer research; however, many – especially Republican offices – were noncommittal about funding increases for the agency, and some were candid about their support for flat funding at best.
We were pleased to host Erik Fatemi, Majority Clerk for the Senate Appropriations Subcommittee on Labor-Health and Human Services-Education, who spoke to attendees at Wednesday's breakfast. Erik reviewed the recent completion of the FY 2011 appropriations process and briefly discussed where things stand with respect to FY 2012. He pointed out that when inflation is accounted for, the recent $320 million cut to NIH is closer to a $1.3 billion cut. He spoke with great candor about the difficulty and uncertainty facing Congress with respect to the current budget discussion for FY 2012. Between the House budget resolution and several parallel efforts in the Senate, "no one knows where this is going to end up." He noted that given the pressure to address the debt limit and insistence by many on focusing the bulk of cuts on non-security, discretionary spending, he could not envision a scenario where NIH does not take some kind of cut, especially because it is a $30 billion line item (more than the entire budget of the Labor Department, for example). He did, however, emphasize that NIH continues to enjoy strong bipartisan support and that "no one wants to cut NIH." He pointed out that with limited funds, even popular programs and agencies are going to be hurt and are pitted against one another for funds.
Erik encouraged attendees to focus messages on NIH' s benefit to state and local economies, job creation potential, and importance to America's global competitiveness. He also encouraged members to focus on communicating with Members of Congress back in the home district at town halls, and through venues other than just on Capitol Hill. Lastly, he encouraged members to think in terms of the larger budget picture – not just that of NIH. In his opinion, what will truly help the NIH budget this year is a larger overall domestic discretionary budget, so that key programs are not competing against each other for such limited dollars.
The four organizations presented the 2011 Cancer Research Advocacy Award to Rep. Ed Markey (D-MA), for his steadfast support for NIH over many years in Congress. In recent years, Rep. Markey has spearheaded a Dear Colleague letter to House appropriators urging support for the agency. Unfortunately, Rep. Markey was unable to attend our reception at the last minute due to votes on the House floor coupled with a last minute Committee markup.ASCO Annual Meeting
The Cancer Center is attempting to track members who are part of the formal program or presenting a poster at theASCO Annual Meeting, June 3-7 in Chicago. Please send information to firstname.lastname@example.org.
**All events are open to anyone interested in attending
Department of Medicine Research Day
Physiology and Biophysics Seminar
Cancer Biology Fellow Seminar
LRI Showcase Seminar
Hematology and Oncology Division Research Conference
Developmental Therapeutics Program Meeting
Tumor Microenvironment and Metastasis Focus Group Meeting
Breast Cancer Detection and Management: Issues for 2011
Taussig Cancer Institute Grand Rounds
Cell Biology Seminar Series
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ASCO Review 2011
Case CCC Annual Scientific Retreat
ADDITIONAL UPCOMING SEMINARS & EVENTS
Race for the Place
International Society for Stem Cell Research (ISSCR) Annual Meeting
Cancer Health Disparities Summit 2011
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED OPPORTUNITIES
DOD CDMRP Prostate Cancer Research Program Collaborative Undergraduate HBCU Student Summer Training Program Award
DOD CDMRP Ovarian Cancer Research Program Pilot Award
NIH BULLETIN – Notices and Funding Opportunities
Notice of Opportunity for Fast Track Entry of Assay Projects for High Throughput Screening into the NIH Roadmap Molecular Libraries Probe Production Centers Network (NOT-RM-11-018)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.